DILTIAZEM HYDROCHLORIDE

DILTIAZEM HYDROCHLORIDE was reported 29669 times

DILTIAZEM HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 49 0.5104
1 SPIROMETRY ABNORMAL 168 0.2809
2 MITE ALLERGY 167 0.2550
3 PULMONARY VASCULITIS 124 0.2305
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 138 0.2066
5 MYCOTIC ALLERGY 169 0.1977
6 TOTAL LUNG CAPACITY ABNORMAL 76 0.1954
7 PROLONGED EXPIRATION 50 0.1908
8 CAPILLARITIS 50 0.1812
9 LUPUS VULGARIS 227 0.1802
10 AMAUROSIS FUGAX 186 0.1727
11 DUST ALLERGY 169 0.1723
12 SEDATION COMPLICATION 435 0.1703
13 GASTROINTESTINAL PROCEDURAL COMPLICATION 35 0.1306
14 CONJUNCTIVITIS ALLERGIC 173 0.1167
15 CREATININE RENAL CLEARANCE DECREASED 464 0.1158
16 DEEP VEIN THROMBOSIS POSTOPERATIVE 226 0.1128
17 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 230 0.1109
18 DISLOCATION OF VERTEBRA 250 0.1095
19 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 79 0.1078
20 SERONEGATIVE ARTHRITIS 119 0.1038
21 RETINITIS 179 0.1035
22 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 78 0.0977
23 X-RAY ABNORMAL 156 0.0872
24 MULTIPLE DRUG THERAPY 64 0.0849
25 NEURITIS 126 0.0816
26 BUNION OPERATION 43 0.0766
27 ALVEOLAR OSTEITIS 32 0.0757
28 CREATININE RENAL CLEARANCE INCREASED 56 0.0749
29 PORPHYRIA ACUTE 99 0.0690
30 BODY TINEA 36 0.0643
31 NORMOCHROMIC NORMOCYTIC ANAEMIA 180 0.0599
32 SWOLLEN JOINT COUNT INCREASED 188 0.0589
33 RHEUMATIC FEVER 261 0.0585
34 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 117 0.0573
35 DUODENAL ULCER PERFORATION 425 0.0571
36 MUSCLE INJURY 469 0.0565
37 BONE EROSION 193 0.0545
38 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 389 0.0542
39 FACET JOINT SYNDROME 172 0.0528
40 HELICOBACTER INFECTION 513 0.0499
41 MITRAL VALVE CALCIFICATION 32 0.0498
42 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 320 0.0492
43 C-REACTIVE PROTEIN 42 0.0453
44 RESPIRATORY SYMPTOM 128 0.0450
45 RHEUMATOID FACTOR POSITIVE 248 0.0429
46 SICK SINUS SYNDROME 49 0.0426
47 BLOOD CALCIUM DECREASED 475 0.0422
48 FOLLICULITIS 422 0.0402
49 FORCED EXPIRATORY VOLUME DECREASED 113 0.0398
50 HAND DEFORMITY 510 0.0388
51 ARTERIOSCLEROSIS CORONARY ARTERY 245 0.0369
52 URINARY TRACT DISORDER 166 0.0368
53 SUSPECTED SUICIDE 171 0.0365
54 LEFT ATRIAL DILATATION 46 0.0361
55 LABILE BLOOD PRESSURE 42 0.0354
56 PEMPHIGUS 432 0.0345
57 HYPERCHOLESTEROLAEMIA 333 0.0345
58 CARDIOACTIVE DRUG LEVEL INCREASED 44 0.0335
59 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 31 0.0334
60 ORTHOSTATIC HYPOTENSION 577 0.0331
61 HAEMORRHAGIC STROKE 258 0.0330
62 BREAST CANCER STAGE III 212 0.0327
63 INCISION SITE PAIN 38 0.0323
64 ANIMAL SCRATCH 31 0.0319
65 WOUND INFECTION 343 0.0313
66 DILATATION ATRIAL 36 0.0308
67 PERIPHERAL VENOUS DISEASE 126 0.0308
68 GRIP STRENGTH DECREASED 267 0.0303
69 INHIBITORY DRUG INTERACTION 48 0.0303
70 DRUG TOLERANCE DECREASED 84 0.0299
71 RHEUMATOID NODULE 81 0.0294
72 JOINT RANGE OF MOTION DECREASED 388 0.0289
73 NODAL RHYTHM 41 0.0280
74 BLOOD PRESSURE DIASTOLIC ABNORMAL 70 0.0275
75 BLOOD PRESSURE SYSTOLIC ABNORMAL 67 0.0271
76 PERICARDITIS 454 0.0270
77 FOOT DEFORMITY 296 0.0267
78 C-REACTIVE PROTEIN ABNORMAL 169 0.0263
79 RALES 151 0.0260
80 IRRITABLE BOWEL SYNDROME 554 0.0258
81 ARTERIOSCLEROSIS 240 0.0255
82 HAEMORRHAGIC ANAEMIA 111 0.0252
83 SYNOVITIS 455 0.0252
84 GLOSSODYNIA 558 0.0249
85 JOINT DISLOCATION 262 0.0248
86 PULMONARY ALVEOLAR HAEMORRHAGE 139 0.0248
87 WALKING AID USER 159 0.0241
88 AUTOIMMUNE DISORDER 231 0.0237
89 COLONIC POLYP 39 0.0236
90 NEUROLOGICAL SYMPTOM 134 0.0234
91 RHONCHI 32 0.0232
92 LEFT VENTRICULAR HYPERTROPHY 99 0.0231
93 FULL BLOOD COUNT ABNORMAL 239 0.0226
94 EXOSTOSIS 206 0.0225
95 NEPHROGENIC ANAEMIA 104 0.0224
96 PULMONARY FIBROSIS 421 0.0219
97 NEPHROGENIC SYSTEMIC FIBROSIS 66 0.0218
98 OBSTRUCTIVE AIRWAYS DISORDER 240 0.0216
99 HYPERPARATHYROIDISM SECONDARY 54 0.0215
100 IMPAIRED HEALING 704 0.0214
101 LUPUS-LIKE SYNDROME 194 0.0214
102 HYPERTENSIVE HEART DISEASE 39 0.0208
103 SPONDYLITIS 73 0.0201
104 ATRIAL FLUTTER 160 0.0200
105 THERAPEUTIC AGENT TOXICITY 64 0.0192
106 VENTRICULAR HYPERTROPHY 48 0.0191
107 SEDATION 501 0.0191
108 LOBAR PNEUMONIA 35 0.0189
109 TUNNEL VISION 35 0.0187
110 ATRIOVENTRICULAR BLOCK FIRST DEGREE 81 0.0187
111 PULMONARY CONGESTION 245 0.0186
112 ATRIAL FIBRILLATION 1793 0.0184
113 LOWER LIMB FRACTURE 351 0.0182
114 FIBROMYALGIA 439 0.0180
115 SCIATICA 287 0.0180
116 LIP DRY 163 0.0179
117 MITRAL VALVE INCOMPETENCE 202 0.0178
118 AORTIC STENOSIS 62 0.0178
119 TRICUSPID VALVE INCOMPETENCE 141 0.0177
120 WOUND 495 0.0177
121 DILATATION VENTRICULAR 37 0.0176
122 ESSENTIAL HYPERTENSION 32 0.0175
123 INFECTION SUSCEPTIBILITY INCREASED 38 0.0173
124 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 292 0.0172
125 OCULAR DISCOMFORT 191 0.0170
126 SKIN INDURATION 35 0.0169
127 TYPE 2 DIABETES MELLITUS 562 0.0167
128 LOWER GASTROINTESTINAL HAEMORRHAGE 122 0.0165
129 PRESCRIBED OVERDOSE 319 0.0165
130 DIVERTICULUM 116 0.0163
131 CAROTID ARTERY STENOSIS 57 0.0163
132 AORTIC ARTERIOSCLEROSIS 42 0.0163
133 SPINAL FUSION SURGERY 66 0.0163
134 GENERALISED OEDEMA 201 0.0162
135 RENAL FUNCTION TEST ABNORMAL 75 0.0161
136 AORTIC VALVE INCOMPETENCE 68 0.0160
137 SINUS PAIN 37 0.0159
138 CARDIOMEGALY 195 0.0158
139 RED BLOOD CELL SEDIMENTATION RATE INCREASED 175 0.0158
140 ANGINA UNSTABLE 102 0.0157
141 HYPERLIPIDAEMIA 186 0.0155
142 BUNDLE BRANCH BLOCK LEFT 66 0.0155
143 NERVE INJURY 171 0.0154
144 DEPRESSIVE SYMPTOM 54 0.0153
145 PRESCRIBED UNDERDOSE 302 0.0151
146 POLYMYALGIA RHEUMATICA 48 0.0151
147 ORTHOPNOEA 48 0.0151
148 ISCHAEMIC CARDIOMYOPATHY 46 0.0150
149 OBESITY 238 0.0149
150 NODULE 193 0.0148
151 RENAL FAILURE CHRONIC 113 0.0147
152 CONTRAINDICATED PRODUCT ADMINISTERED 443 0.0146
153 ULCER HAEMORRHAGE 99 0.0146
154 MULTIPLE INJURIES 92 0.0146
155 ATRIOVENTRICULAR BLOCK SECOND DEGREE 44 0.0145
156 EAR CONGESTION 39 0.0144
157 BURSITIS 174 0.0143
158 WHEEZING 848 0.0143
159 ATRIOVENTRICULAR BLOCK COMPLETE 92 0.0137
160 DEPRESSED LEVEL OF CONSCIOUSNESS 543 0.0137
161 BRONCHIECTASIS 92 0.0136
162 SYSTEMIC LUPUS ERYTHEMATOSUS 478 0.0135
163 CORONARY ARTERY DISEASE 402 0.0133
164 EYE INJURY 40 0.0132
165 BLOOD PRESSURE INADEQUATELY CONTROLLED 79 0.0131
166 ECONOMIC PROBLEM 198 0.0131
167 HIP ARTHROPLASTY 200 0.0130
168 HEPATIC CIRRHOSIS 241 0.0128
169 HEAD DISCOMFORT 226 0.0128
170 SUPRAVENTRICULAR EXTRASYSTOLES 43 0.0127
171 ATELECTASIS 123 0.0127
172 CORONARY ARTERY STENOSIS 64 0.0127
173 BUNDLE BRANCH BLOCK RIGHT 58 0.0126
174 INJURY 888 0.0126
175 BLADDER PAIN 40 0.0126
176 BLOOD PRESSURE SYSTOLIC INCREASED 244 0.0125
177 SUPRAVENTRICULAR TACHYCARDIA 119 0.0124
178 HYPOXIA 432 0.0123
179 VENTRICULAR EXTRASYSTOLES 127 0.0122
180 LIVE BIRTH 101 0.0121
181 COGNITIVE DISORDER 562 0.0120
182 CARDIAC FAILURE CONGESTIVE 966 0.0120
183 MOBILITY DECREASED 862 0.0120
184 MYOCARDIAL ISCHAEMIA 136 0.0119
185 WOUND COMPLICATION 41 0.0119
186 CARDIAC MURMUR 103 0.0119
187 PERIPHERAL VASCULAR DISORDER 61 0.0118
188 RESPIRATION ABNORMAL 81 0.0117
189 OSTEOARTHRITIS 495 0.0117
190 PARANASAL SINUS DISCOMFORT 44 0.0116
191 TENOSYNOVITIS 32 0.0116
192 LIVER INJURY 282 0.0115
193 HAEMATEMESIS 289 0.0114
194 ATRIOVENTRICULAR BLOCK 88 0.0114
195 GLUCOSE TOLERANCE IMPAIRED 67 0.0113
196 ANGINA PECTORIS 319 0.0111
197 LOWER RESPIRATORY TRACT INFECTION 506 0.0111
198 CHEST X-RAY ABNORMAL 34 0.0111
199 OEDEMA 599 0.0110
200 TROPONIN INCREASED 84 0.0110
201 SKIN HYPERTROPHY 31 0.0110
202 LUMBAR SPINAL STENOSIS 32 0.0109
203 SPINAL OSTEOARTHRITIS 96 0.0109
204 COAGULOPATHY 182 0.0109
205 MATERNAL EXPOSURE TIMING UNSPECIFIED 41 0.0109
206 VASCULITIS 127 0.0109
207 MYOPATHY 94 0.0109
208 PROTHROMBIN TIME PROLONGED 65 0.0109
209 HEART RATE IRREGULAR 244 0.0108
210 EMBOLIC STROKE 38 0.0108
211 DIASTOLIC DYSFUNCTION 33 0.0107
212 SINUS BRADYCARDIA 103 0.0106
213 BLISTER 598 0.0106
214 REBOUND ACID HYPERSECRETION 32 0.0106
215 RENAL CYST 84 0.0106
216 RHINITIS ALLERGIC 47 0.0105
217 HEART RATE DECREASED 370 0.0105
218 CEREBRAL ATROPHY 42 0.0105
219 DIABETIC NEUROPATHY 52 0.0105
220 PRESYNCOPE 255 0.0105
221 SPINAL COLUMN STENOSIS 49 0.0104
222 BLOOD CHOLESTEROL INCREASED 483 0.0104
223 ECCHYMOSIS 71 0.0103
224 CARDIAC VALVE DISEASE 59 0.0103
225 DIVERTICULUM INTESTINAL 45 0.0103
226 VENTRICULAR HYPOKINESIA 33 0.0103
227 BRADYCARDIA 544 0.0102
228 CANDIDIASIS 41 0.0102
229 JOINT STIFFNESS 266 0.0101
230 NON-CARDIAC CHEST PAIN 32 0.0101
231 ALTERED STATE OF CONSCIOUSNESS 219 0.0101
232 BENIGN PROSTATIC HYPERPLASIA 52 0.0101
233 ARTHROPATHY 554 0.0100
234 PEPTIC ULCER 33 0.0099
235 BREATH SOUNDS ABNORMAL 49 0.0099
236 CARDIOGENIC SHOCK 141 0.0098
237 HAEMATURIA 336 0.0098
238 HIATUS HERNIA 127 0.0098
239 HYPOVOLAEMIA 57 0.0097
240 TOOTH INFECTION 128 0.0097
241 FOOT OPERATION 48 0.0097
242 LUNG DISORDER 474 0.0097
243 BLOOD PRESSURE DIASTOLIC DECREASED 71 0.0096
244 GAIT INABILITY 321 0.0096
245 KNEE ARTHROPLASTY 202 0.0096
246 DIFFICULTY IN WALKING 33 0.0096
247 PRODUCTIVE COUGH 457 0.0096
248 DELIRIUM 332 0.0096
249 BALANCE DISORDER 824 0.0095
250 HEPATIC CYST 32 0.0094
251 PHOTOPHOBIA 177 0.0094
252 RESPIRATORY TRACT CONGESTION 149 0.0094
253 APPETITE DISORDER 62 0.0093
254 UPPER RESPIRATORY TRACT INFECTION 432 0.0093
255 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 485 0.0093
256 PSORIATIC ARTHROPATHY 377 0.0093
257 FLANK PAIN 87 0.0093
258 CORONARY ARTERY OCCLUSION 127 0.0093
259 CONTUSION 890 0.0092
260 OEDEMA PERIPHERAL 1126 0.0092
261 WOUND SECRETION 36 0.0092
262 LUNG NEOPLASM 39 0.0091
263 DYSPNOEA EXERTIONAL 343 0.0091
264 IRON DEFICIENCY ANAEMIA 84 0.0091
265 AZOTAEMIA 36 0.0090
266 DISCOMFORT 549 0.0090
267 RENAL FAILURE ACUTE 381 0.0090
268 DISABILITY 177 0.0089
269 HAEMOPTYSIS 247 0.0088
270 GASTRITIS EROSIVE 41 0.0088
271 INTERNATIONAL NORMALISED RATIO INCREASED 250 0.0088
272 ASTHMA 991 0.0088
273 EAR INFECTION 233 0.0087
274 HEPATIC ENZYME INCREASED 595 0.0087
275 INFUSION RELATED REACTION 571 0.0086
276 SLEEP DISORDER 608 0.0086
277 UPPER GASTROINTESTINAL HAEMORRHAGE 143 0.0085
278 PULMONARY HYPERTENSION 177 0.0085
279 GASTROINTESTINAL HAEMORRHAGE 708 0.0085
280 OSTEOPOROSIS 346 0.0084
281 ASCITES 247 0.0084
282 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 403 0.0084
283 ANAL ABSCESS 45 0.0083
284 SLEEP APNOEA SYNDROME 159 0.0083
285 ROAD TRAFFIC ACCIDENT 348 0.0083
286 POLYP 54 0.0082
287 CARDIO-RESPIRATORY ARREST 343 0.0082
288 INTESTINAL ISCHAEMIA 45 0.0082
289 INTERNATIONAL NORMALISED RATIO DECREASED 33 0.0081
290 NIGHT SWEATS 262 0.0081
291 END STAGE RENAL DISEASE 148 0.0081
292 RECTAL HAEMORRHAGE 348 0.0081
293 BLOOD UREA INCREASED 135 0.0081
294 ACUTE RESPIRATORY FAILURE 155 0.0080
295 STOMATITIS 485 0.0080
296 INTERVERTEBRAL DISC DISORDER 34 0.0080
297 BRONCHITIS 588 0.0079
298 NASAL POLYPS 39 0.0079
299 ELECTROCARDIOGRAM ABNORMAL 62 0.0079
300 INTERVERTEBRAL DISC DEGENERATION 73 0.0079
301 KIDNEY INFECTION 153 0.0078
302 ONYCHOMYCOSIS 34 0.0077
303 DIPLOPIA 200 0.0077
304 CATHETERISATION CARDIAC 34 0.0077
305 TORSADE DE POINTES 60 0.0076
306 SKIN ATROPHY 44 0.0076
307 EXERCISE TOLERANCE DECREASED 44 0.0076
308 C-REACTIVE PROTEIN INCREASED 278 0.0076
309 TACHYCARDIA 678 0.0076
310 PROTEIN URINE PRESENT 38 0.0076
311 SWELLING 713 0.0076
312 HYPOTENSION 1522 0.0076
313 NEPHROLITHIASIS 348 0.0076
314 CARDIAC FLUTTER 49 0.0076
315 ARTERIAL OCCLUSIVE DISEASE 59 0.0075
316 SINUSITIS 769 0.0075
317 HYPOTHYROIDISM 239 0.0075
318 ADRENAL INSUFFICIENCY 90 0.0074
319 HEART RATE ABNORMAL 41 0.0073
320 INCREASED TENDENCY TO BRUISE 67 0.0073
321 UMBILICAL HERNIA 34 0.0073
322 BLOOD IRON DECREASED 86 0.0072
323 ACUTE CORONARY SYNDROME 60 0.0072
324 ABDOMINAL HERNIA 33 0.0072
325 VENTRICULAR TACHYCARDIA 119 0.0072
326 HYPERTHYROIDISM 104 0.0072
327 CHEST PAIN 1330 0.0072
328 EXTRASYSTOLES 50 0.0072
329 RENAL INJURY 212 0.0071
330 CORONARY ARTERIAL STENT INSERTION 36 0.0071
331 DUODENAL ULCER 50 0.0071
332 SPUTUM DISCOLOURED 67 0.0071
333 MULTI-ORGAN FAILURE 122 0.0070
334 MUSCLE STRAIN 61 0.0070
335 LIVER FUNCTION TEST INCREASED 151 0.0070
336 LUNG INFILTRATION 62 0.0070
337 DECUBITUS ULCER 57 0.0070
338 VISUAL DISTURBANCE 40 0.0070
339 BLOOD URINE PRESENT 131 0.0069
340 DYSLIPIDAEMIA 35 0.0069
341 JOINT SWELLING 830 0.0069
342 HEART RATE INCREASED 675 0.0068
343 SKIN TIGHTNESS 32 0.0068
344 EAR PAIN 132 0.0068
345 HAEMORRHOIDAL HAEMORRHAGE 33 0.0068
346 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 34 0.0067
347 BLOOD ALBUMIN DECREASED 53 0.0067
348 BLEPHAROSPASM 42 0.0067
349 HAEMODIALYSIS 56 0.0067
350 PURPURA 59 0.0067
351 HYPERKALAEMIA 233 0.0066
352 WEIGHT FLUCTUATION 69 0.0066
353 DERMATITIS EXFOLIATIVE 33 0.0066
354 MUSCULOSKELETAL PAIN 344 0.0066
355 AMNESIA 427 0.0066
356 BLADDER DISORDER 65 0.0065
357 CARDIAC PACEMAKER INSERTION 39 0.0065
358 HYPERGLYCAEMIA 238 0.0065
359 BLOOD COUNT ABNORMAL 99 0.0065
360 ARRHYTHMIA 307 0.0065
361 PERIPHERAL SWELLING 995 0.0065
362 ACUTE MYOCARDIAL INFARCTION 190 0.0064
363 LIMB INJURY 175 0.0064
364 ANEURYSM 32 0.0064
365 BODY TEMPERATURE DECREASED 63 0.0064
366 RENAL FAILURE 847 0.0064
367 TRANSIENT ISCHAEMIC ATTACK 215 0.0064
368 FAILURE TO THRIVE 33 0.0063
369 ANHEDONIA 167 0.0063
370 SYNCOPE 635 0.0063
371 COMPRESSION FRACTURE 34 0.0063
372 MUSCULOSKELETAL STIFFNESS 554 0.0063
373 PLEURAL EFFUSION 384 0.0063
374 VENTRICULAR FIBRILLATION 70 0.0063
375 REFUSAL OF TREATMENT BY PATIENT 41 0.0063
376 LEFT VENTRICULAR DYSFUNCTION 42 0.0063
377 NOCTURIA 76 0.0063
378 SKIN LACERATION 68 0.0062
379 PHARYNGOLARYNGEAL PAIN 33 0.0062
380 THERMAL BURN 44 0.0062
381 HYPERTENSION 1312 0.0062
382 BLOOD PRESSURE INCREASED 946 0.0062
383 HYPOAESTHESIA 922 0.0062
384 TINNITUS 283 0.0062
385 BLOOD POTASSIUM INCREASED 100 0.0062
386 FEAR 165 0.0061
387 ILL-DEFINED DISORDER 371 0.0061
388 CARDIOMYOPATHY 90 0.0061
389 CORONARY ARTERY BYPASS 35 0.0061
390 BLINDNESS 248 0.0061
391 MALNUTRITION 68 0.0061
392 COLITIS ISCHAEMIC 41 0.0061
393 POLYARTHRITIS 32 0.0061
394 MEDICATION ERROR 337 0.0061
395 HAEMATOCRIT DECREASED 120 0.0060
396 GASTROOESOPHAGEAL REFLUX DISEASE 487 0.0060
397 EMPHYSEMA 61 0.0060
398 FLUID OVERLOAD 88 0.0060
399 PHARMACEUTICAL PRODUCT COMPLAINT 157 0.0060
400 HUNGER 84 0.0060
401 TOOTH DISORDER 134 0.0060
402 GOUT 108 0.0060
403 CARDIAC FAILURE ACUTE 40 0.0060
404 INFECTION 869 0.0060
405 FALL 1995 0.0060
406 CELLULITIS 302 0.0060
407 INTERNAL HAEMORRHAGE 68 0.0059
408 DYSPNOEA 3368 0.0059
409 DIVERTICULITIS 163 0.0059
410 OESOPHAGITIS 64 0.0059
411 MENTAL STATUS CHANGES 161 0.0058
412 BLOOD PRESSURE FLUCTUATION 139 0.0058
413 AORTIC ANEURYSM 44 0.0058
414 UNRESPONSIVE TO STIMULI 149 0.0058
415 BLOOD TRIGLYCERIDES INCREASED 102 0.0058
416 LIVER DISORDER 256 0.0058
417 HYPOKALAEMIA 266 0.0058
418 COMPLETED SUICIDE 480 0.0058
419 HYPERSENSITIVITY 1069 0.0058
420 RESPIRATORY RATE INCREASED 51 0.0057
421 DRY MOUTH 466 0.0057
422 PULMONARY OEDEMA 257 0.0057
423 STENT PLACEMENT 46 0.0057
424 CONFUSIONAL STATE 921 0.0057
425 HAEMORRHOIDS 111 0.0057
426 ASPIRATION 62 0.0057
427 SEASONAL ALLERGY 80 0.0056
428 MUSCULOSKELETAL CHEST PAIN 87 0.0056
429 PRE-EXISTING CONDITION IMPROVED 35 0.0056
430 THERAPEUTIC PRODUCT EFFECT DECREASED 251 0.0056
431 NAIL DISORDER 49 0.0056
432 ANOREXIA 72 0.0056
433 MYOSITIS 50 0.0056
434 OXYGEN SATURATION DECREASED 313 0.0056
435 SPINAL COMPRESSION FRACTURE 46 0.0056
436 RHEUMATOID ARTHRITIS 630 0.0055
437 DRUG-INDUCED LIVER INJURY 174 0.0055
438 ARTHRITIS 436 0.0055
439 TRANSFUSION 58 0.0055
440 LEUKOCYTOSIS 100 0.0055
441 BACK INJURY 60 0.0055
442 VITAMIN D DECREASED 47 0.0055
443 ACIDOSIS 42 0.0055
444 GASTRITIS 144 0.0055
445 CHRONIC KIDNEY DISEASE 415 0.0055
446 ORAL DISORDER 40 0.0055
447 BLOOD MAGNESIUM DECREASED 47 0.0054
448 COMA 259 0.0054
449 BODY HEIGHT DECREASED 58 0.0054
450 WHITE BLOOD CELL COUNT INCREASED 207 0.0054
451 NASOPHARYNGITIS 994 0.0054
452 THROMBOSIS 433 0.0054
453 CHOLECYSTITIS 64 0.0054
454 FLUID RETENTION 272 0.0053
455 CONSTIPATION 1165 0.0053
456 EJECTION FRACTION DECREASED 83 0.0053
457 FREQUENT BOWEL MOVEMENTS 144 0.0053
458 DRUG INTERACTION 845 0.0053
459 BRONCHOSPASM 76 0.0053
460 EYE PAIN 300 0.0053
461 THERAPY NON-RESPONDER 239 0.0053
462 HYPOKINESIA 77 0.0053
463 PALPITATIONS 620 0.0053
464 JOINT INJURY 113 0.0053
465 POOR QUALITY SLEEP 113 0.0052
466 CARPAL TUNNEL SYNDROME 73 0.0052
467 SINUS DISORDER 103 0.0052
468 RENAL PAIN 55 0.0052
469 NEUTROPHIL COUNT INCREASED 53 0.0052
470 PAIN IN EXTREMITY 1520 0.0052
471 OLIGURIA 32 0.0051
472 BODY TEMPERATURE INCREASED 105 0.0051
473 RIGHT VENTRICULAR FAILURE 36 0.0051
474 MUSCULAR WEAKNESS 583 0.0051
475 PNEUMONIA 1658 0.0051
476 GASTROINTESTINAL DISORDER 458 0.0051
477 HYPOMAGNESAEMIA 71 0.0051
478 HAEMATOMA 132 0.0051
479 DYSPEPSIA 501 0.0051
480 BLOOD POTASSIUM DECREASED 153 0.0051
481 GENERAL PHYSICAL HEALTH DETERIORATION 587 0.0051
482 HAEMOGLOBIN DECREASED 518 0.0050
483 SMALL INTESTINAL OBSTRUCTION 62 0.0050
484 WEIGHT DECREASED 1405 0.0050
485 HYPERTRANSAMINASAEMIA 35 0.0050
486 FEELING COLD 140 0.0050
487 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 39 0.0050
488 ORAL HERPES 98 0.0050
489 SCOLIOSIS 31 0.0050
490 LACERATION 47 0.0050
491 RENAL TUBULAR NECROSIS 49 0.0050
492 DRUG INTOLERANCE 481 0.0050
493 ABDOMINAL DISCOMFORT 824 0.0049
494 MYOCARDIAL INFARCTION 855 0.0049
495 MUSCLE DISORDER 39 0.0048
496 MUSCLE ATROPHY 61 0.0048
497 DECREASED APPETITE 1118 0.0048
498 CHEST DISCOMFORT 492 0.0048
499 SEPSIS 535 0.0048
500 POLLAKIURIA 200 0.0048
501 PRODUCT ODOUR ABNORMAL 50 0.0048
502 MACULAR DEGENERATION 57 0.0048
503 RIB FRACTURE 98 0.0048
504 TOXICITY TO VARIOUS AGENTS 803 0.0048
505 RESPIRATORY FAILURE 347 0.0048
506 FAECES DISCOLOURED 103 0.0047
507 ROTATOR CUFF SYNDROME 61 0.0047
508 DIABETES MELLITUS INADEQUATE CONTROL 84 0.0047
509 COUGH 1329 0.0047
510 ELECTROLYTE IMBALANCE 55 0.0047
511 INCONTINENCE 50 0.0047
512 BLOOD SODIUM DECREASED 89 0.0047
513 INTERVERTEBRAL DISC PROTRUSION 103 0.0047
514 DYSURIA 173 0.0047
515 WEIGHT INCREASED 1051 0.0047
516 URINE OUTPUT DECREASED 41 0.0047
517 INSOMNIA 1247 0.0047
518 ASTHENIA 1760 0.0047
519 CYSTITIS 149 0.0047
520 WRIST FRACTURE 56 0.0047
521 CARDIAC ARREST 384 0.0046
522 CHILLS 543 0.0046
523 UPPER-AIRWAY COUGH SYNDROME 38 0.0046
524 CARDIAC DISORDER 431 0.0046
525 LYMPHOCYTE COUNT DECREASED 81 0.0046
526 INTENTIONAL PRODUCT USE ISSUE 400 0.0046
527 BREAST CANCER STAGE I 42 0.0045
528 BLOOD PRESSURE DECREASED 301 0.0045
529 INFLAMMATION 233 0.0045
530 LUNG INFECTION 70 0.0045
531 EYE HAEMORRHAGE 60 0.0045
532 BLOOD CREATINE PHOSPHOKINASE INCREASED 129 0.0045
533 SHOCK 103 0.0045
534 DIZZINESS 2219 0.0044
535 UROSEPSIS 41 0.0044
536 PULMONARY EMBOLISM 421 0.0044
537 SHOCK HAEMORRHAGIC 36 0.0044
538 ANXIETY 1257 0.0044
539 DEMENTIA 123 0.0044
540 HYPOAESTHESIA ORAL 66 0.0044
541 HAND FRACTURE 31 0.0044
542 MASS 61 0.0044
543 MULTIPLE ALLERGIES 34 0.0043
544 MOVEMENT DISORDER 139 0.0043
545 POST PROCEDURAL COMPLICATION 83 0.0043
546 RHABDOMYOLYSIS 180 0.0043
547 PSEUDOMONAS INFECTION 37 0.0043
548 PULMONARY MASS 64 0.0043
549 SINUS TACHYCARDIA 61 0.0043
550 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 305 0.0043
551 POLYURIA 35 0.0043
552 INFUSION SITE ERYTHEMA 36 0.0043
553 SCAR 73 0.0043
554 CLOSTRIDIUM DIFFICILE COLITIS 45 0.0042
555 CHOLELITHIASIS 139 0.0042
556 BLOOD ALKALINE PHOSPHATASE INCREASED 105 0.0042
557 GAIT DISTURBANCE 808 0.0042
558 GROIN PAIN 37 0.0042
559 ABASIA 104 0.0042
560 CATARACT 250 0.0042
561 UNEVALUABLE EVENT 317 0.0042
562 RASH PRURITIC 227 0.0042
563 BACK DISORDER 68 0.0042
564 ALOPECIA 821 0.0042
565 GASTRIC ULCER 79 0.0042
566 URINARY TRACT INFECTION 709 0.0042
567 LIGAMENT SPRAIN 41 0.0041
568 OSTEOMYELITIS 75 0.0041
569 ABDOMINAL PAIN UPPER 850 0.0041
570 MUSCULOSKELETAL DISCOMFORT 71 0.0041
571 RESPIRATORY DISORDER 123 0.0041
572 GASTROENTERITIS 60 0.0041
573 DIABETES MELLITUS 313 0.0041
574 BLOOD CALCIUM INCREASED 36 0.0041
575 BLOOD CREATININE INCREASED 267 0.0041
576 OSTEOPENIA 62 0.0041
577 EPISTAXIS 305 0.0041
578 CONDITION AGGRAVATED 1239 0.0041
579 PARAESTHESIA 641 0.0041
580 DEFORMITY 38 0.0041
581 PERICARDIAL EFFUSION 94 0.0041
582 RESPIRATORY DISTRESS 112 0.0041
583 SUBDURAL HAEMATOMA 58 0.0040
584 DEHYDRATION 540 0.0040
585 SPINAL FRACTURE 81 0.0040
586 PNEUMONIA BACTERIAL 37 0.0040
587 CHOLECYSTECTOMY 46 0.0040
588 PAIN 2470 0.0040
589 NERVOUSNESS 210 0.0040
590 PULMONARY ARTERIAL HYPERTENSION 58 0.0040
591 VITAMIN D DEFICIENCY 39 0.0040
592 PLATELET COUNT INCREASED 52 0.0040
593 SENSORY DISTURBANCE 64 0.0040
594 SCRATCH 42 0.0040
595 PELVIC FRACTURE 31 0.0040
596 HEPATIC STEATOSIS 74 0.0040
597 IMPAIRED QUALITY OF LIFE 57 0.0040
598 ABDOMINAL PAIN 922 0.0040
599 ARTHRALGIA 1645 0.0040
600 BONE DISORDER 72 0.0039
601 DEPRESSION 895 0.0039
602 SINUS CONGESTION 53 0.0039
603 FACIAL PAIN 35 0.0039
604 DIZZINESS POSTURAL 38 0.0039
605 NECK PAIN 219 0.0039
606 HYPOGLYCAEMIA 189 0.0039
607 DRUG LEVEL INCREASED 64 0.0039
608 MYALGIA 657 0.0039
609 CEREBROVASCULAR ACCIDENT 653 0.0039
610 RESTLESS LEGS SYNDROME 70 0.0038
611 URINARY INCONTINENCE 114 0.0038
612 NASAL CONGESTION 226 0.0038
613 RESPIRATORY ARREST 106 0.0038
614 PANCREATITIS 203 0.0038
615 HYPONATRAEMIA 216 0.0038
616 PYREXIA 1323 0.0038
617 BLOOD PRESSURE ABNORMAL 76 0.0038
618 STAPHYLOCOCCAL INFECTION 126 0.0038
619 ANAEMIA 728 0.0038
620 FEELING HOT 234 0.0038
621 HAEMORRHAGE INTRACRANIAL 57 0.0038
622 PYELONEPHRITIS 33 0.0038
623 RESPIRATORY TRACT INFECTION 99 0.0038
624 SENSATION OF FOREIGN BODY 32 0.0038
625 MEMORY IMPAIRMENT 521 0.0038
626 POST PROCEDURAL HAEMORRHAGE 44 0.0038
627 RHINORRHOEA 244 0.0038
628 MELAENA 83 0.0038
629 CARDIAC FAILURE 302 0.0038
630 SPLENOMEGALY 44 0.0038
631 ANKLE FRACTURE 58 0.0037
632 PREGNANCY 75 0.0037
633 GLAUCOMA 72 0.0037
634 ACTIVITIES OF DAILY LIVING IMPAIRED 74 0.0037
635 OROPHARYNGEAL PAIN 345 0.0037
636 URTICARIA 623 0.0037
637 HYPERTENSIVE CRISIS 41 0.0037
638 BACK PAIN 856 0.0037
639 MUSCLE SPASMS 676 0.0037
640 LIMB DISCOMFORT 113 0.0036
641 INFUSION SITE PAIN 47 0.0036
642 LOCALISED INFECTION 88 0.0036
643 DENTAL CARIES 40 0.0036
644 DYSARTHRIA 136 0.0036
645 PRURITUS 1385 0.0036
646 VISION BLURRED 494 0.0036
647 BASAL CELL CARCINOMA 56 0.0036
648 GINGIVAL BLEEDING 49 0.0036
649 GALLBLADDER DISORDER 64 0.0036
650 FATIGUE 2790 0.0036
651 ORAL CANDIDIASIS 47 0.0036
652 HERPES ZOSTER 205 0.0036
653 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 61 0.0036
654 TOOTH ABSCESS 36 0.0035
655 NEPHROPATHY 33 0.0035
656 MIDDLE INSOMNIA 66 0.0035
657 CIRCULATORY COLLAPSE 60 0.0035
658 GASTROENTERITIS VIRAL 63 0.0035
659 PULMONARY THROMBOSIS 38 0.0035
660 HEAD INJURY 110 0.0035
661 ACUTE KIDNEY INJURY 531 0.0035
662 DISORIENTATION 137 0.0035
663 ACUTE HEPATIC FAILURE 47 0.0034
664 DYSPHONIA 201 0.0034
665 ABDOMINAL DISTENSION 358 0.0034
666 SWOLLEN TONGUE 107 0.0034
667 COLITIS ULCERATIVE 153 0.0034
668 HIP FRACTURE 110 0.0034
669 BLOOD TEST ABNORMAL 48 0.0034
670 RENAL IMPAIRMENT 287 0.0034
671 MALAISE 1494 0.0034
672 CEREBRAL INFARCTION 83 0.0034
673 VISUAL IMPAIRMENT 420 0.0034
674 TACHYPNOEA 46 0.0034
675 PHARYNGEAL OEDEMA 52 0.0034
676 DRUG TOXICITY 46 0.0034
677 HYPOACUSIS 145 0.0034
678 APHONIA 47 0.0034
679 TENDERNESS 35 0.0034
680 DIARRHOEA 2162 0.0033
681 BEDRIDDEN 44 0.0033
682 DRY THROAT 34 0.0033
683 LIVER FUNCTION TEST ABNORMAL 97 0.0033
684 FULL BLOOD COUNT DECREASED 67 0.0033
685 LETHARGY 191 0.0033
686 TASTE DISORDER 67 0.0033
687 HEADACHE 2063 0.0033
688 FOOT FRACTURE 62 0.0033
689 LABORATORY TEST ABNORMAL 96 0.0032
690 SKIN DISCOLOURATION 149 0.0032
691 ORAL DISCOMFORT 45 0.0032
692 SKIN ULCER 83 0.0032
693 SKIN INFECTION 36 0.0032
694 TREMOR 532 0.0032
695 PNEUMONIA ASPIRATION 80 0.0032
696 TUBULOINTERSTITIAL NEPHRITIS 60 0.0032
697 LOSS OF CONSCIOUSNESS 409 0.0032
698 FLATULENCE 181 0.0032
699 INFLUENZA 355 0.0032
700 DIALYSIS 45 0.0032
701 NAUSEA 2508 0.0032
702 METABOLIC ACIDOSIS 101 0.0032
703 SOMNOLENCE 634 0.0031
704 CONVULSION 180 0.0031
705 AGEUSIA 78 0.0031
706 NEURALGIA 76 0.0031
707 BACTERAEMIA 37 0.0031
708 SECRETION DISCHARGE 39 0.0031
709 VOMITING 1464 0.0031
710 TREATMENT FAILURE 257 0.0031
711 RASH MACULO-PAPULAR 69 0.0031
712 ERUCTATION 60 0.0031
713 DYSGEUSIA 230 0.0031
714 RENAL DISORDER 144 0.0031
715 EOSINOPHILIA 54 0.0031
716 ABSCESS 49 0.0031
717 DECREASED ACTIVITY 33 0.0031
718 CYANOSIS 48 0.0030
719 PRURITUS GENERALISED 66 0.0030
720 DYSSTASIA 89 0.0030
721 BLOOD LACTATE DEHYDROGENASE INCREASED 48 0.0030
722 ULCER 48 0.0030
723 SKIN LESION 82 0.0030
724 LOCAL SWELLING 52 0.0030
725 PROSTATIC SPECIFIC ANTIGEN INCREASED 41 0.0030
726 HAEMATOCHEZIA 164 0.0030
727 THIRST 53 0.0030
728 BURNING SENSATION 208 0.0030
729 MUSCLE TIGHTNESS 48 0.0030
730 CARDIOVASCULAR DISORDER 75 0.0030
731 HEMIPARESIS 50 0.0029
732 POISONING 37 0.0029
733 FEELING JITTERY 56 0.0029
734 THERAPEUTIC RESPONSE DECREASED 178 0.0029
735 PAIN IN JAW 83 0.0029
736 HYPERHIDROSIS 376 0.0029
737 DYSPHAGIA 277 0.0029
738 ASPARTATE AMINOTRANSFERASE INCREASED 155 0.0029
739 SPINAL PAIN 34 0.0029
740 ADVERSE EVENT 267 0.0029
741 GASTRIC DISORDER 99 0.0029
742 IMMUNODEFICIENCY 43 0.0029
743 SKIN CANCER 62 0.0029
744 DEEP VEIN THROMBOSIS 187 0.0029
745 THROAT IRRITATION 129 0.0029
746 FEMUR FRACTURE 89 0.0029
747 GASTRIC HAEMORRHAGE 33 0.0029
748 THYROID DISORDER 44 0.0029
749 RASH 1244 0.0029
750 HEPATITIS 73 0.0029
751 FACE OEDEMA 48 0.0028
752 PERIPHERAL COLDNESS 39 0.0028
753 SKIN HAEMORRHAGE 42 0.0028
754 PANIC ATTACK 103 0.0028
755 ILEUS 35 0.0028
756 HAIR COLOUR CHANGES 35 0.0028
757 INTESTINAL OBSTRUCTION 106 0.0028
758 ALANINE AMINOTRANSFERASE INCREASED 172 0.0028
759 VIRAL INFECTION 93 0.0028
760 HERNIA 54 0.0028
761 SKIN DISORDER 93 0.0028
762 ORAL PAIN 62 0.0028
763 DRUG ERUPTION 49 0.0028
764 BLINDNESS UNILATERAL 39 0.0028
765 ERECTILE DYSFUNCTION 71 0.0028
766 TREATMENT NONCOMPLIANCE 151 0.0028
767 PANCREATITIS ACUTE 62 0.0028
768 MIGRAINE 262 0.0027
769 BLOOD GLUCOSE DECREASED 131 0.0027
770 EMOTIONAL DISORDER 84 0.0027
771 HYPERSOMNIA 78 0.0027
772 LYMPHOMA 42 0.0027
773 IMPAIRED WORK ABILITY 58 0.0027
774 MOUTH ULCERATION 57 0.0027
775 MYELODYSPLASTIC SYNDROME 39 0.0027
776 ABNORMAL DREAMS 74 0.0027
777 DEAFNESS 70 0.0027
778 PROCEDURAL PAIN 74 0.0027
779 COLD SWEAT 47 0.0027
780 UPPER LIMB FRACTURE 53 0.0027
781 VISUAL ACUITY REDUCED 88 0.0026
782 PNEUMOTHORAX 42 0.0026
783 TENDONITIS 41 0.0026
784 BLOOD GLUCOSE INCREASED 498 0.0026
785 URINARY RETENTION 88 0.0026
786 THINKING ABNORMAL 49 0.0026
787 OSTEONECROSIS OF JAW 65 0.0026
788 BACTERIAL INFECTION 49 0.0026
789 RED BLOOD CELL COUNT DECREASED 75 0.0026
790 HAEMORRHAGE 274 0.0026
791 PRODUCT SUBSTITUTION ISSUE 150 0.0026
792 DEPRESSED MOOD 137 0.0026
793 ADVERSE DRUG REACTION 232 0.0026
794 COORDINATION ABNORMAL 36 0.0026
795 DELUSION 40 0.0026
796 FEELING ABNORMAL 616 0.0026
797 INCREASED APPETITE 49 0.0026
798 VERTIGO 156 0.0026
799 SKIN FISSURES 50 0.0026
800 ELECTROCARDIOGRAM QT PROLONGED 92 0.0026
801 NO THERAPEUTIC RESPONSE 31 0.0025
802 QUALITY OF LIFE DECREASED 34 0.0025
803 MATERNAL EXPOSURE DURING PREGNANCY 225 0.0025
804 MUSCLE SPASTICITY 31 0.0025
805 THROAT TIGHTNESS 68 0.0025
806 NEUROPATHY PERIPHERAL 239 0.0025
807 SPEECH DISORDER 131 0.0025
808 PHARYNGITIS 31 0.0025
809 PARAESTHESIA ORAL 36 0.0025
810 SKIN EXFOLIATION 210 0.0025
811 CEREBRAL HAEMORRHAGE 89 0.0025
812 ENCEPHALOPATHY 61 0.0025
813 COLON CANCER 37 0.0025
814 CHROMATURIA 56 0.0025
815 FLUSHING 252 0.0025
816 SWELLING FACE 161 0.0025
817 EYE DISORDER 81 0.0025
818 FUNGAL INFECTION 82 0.0025
819 APHASIA 74 0.0024
820 PARALYSIS 35 0.0024
821 EATING DISORDER 52 0.0024
822 BLOOD GLUCOSE ABNORMAL 45 0.0024
823 TOOTHACHE 44 0.0024
824 HALLUCINATION 183 0.0024
825 EMOTIONAL DISTRESS 290 0.0024
826 HAIR TEXTURE ABNORMAL 32 0.0024
827 RETCHING 51 0.0024
828 HYPOPHAGIA 61 0.0024
829 LACRIMATION INCREASED 72 0.0024
830 LYMPHADENOPATHY 84 0.0024
831 LIP SWELLING 79 0.0024
832 HALLUCINATION, VISUAL 50 0.0024
833 SEPTIC SHOCK 103 0.0024
834 INSURANCE ISSUE 36 0.0024
835 THROMBOCYTOPENIA 263 0.0023
836 IMPAIRED GASTRIC EMPTYING 32 0.0023
837 DISSEMINATED INTRAVASCULAR COAGULATION 33 0.0023
838 INTENTIONAL DRUG MISUSE 49 0.0023
839 CLOSTRIDIUM DIFFICILE INFECTION 51 0.0023
840 HOT FLUSH 176 0.0023
841 PROTEINURIA 44 0.0023
842 PLATELET COUNT DECREASED 246 0.0023
843 PRODUCT TASTE ABNORMAL 31 0.0023
844 RASH GENERALISED 59 0.0023
845 CANDIDA INFECTION 38 0.0022
846 DRY EYE 112 0.0022
847 PALLOR 61 0.0022
848 CHOLESTASIS 43 0.0022
849 BONE PAIN 131 0.0022
850 PSORIASIS 292 0.0022
851 PRODUCT USE IN UNAPPROVED INDICATION 554 0.0022
852 NIGHTMARE 77 0.0022
853 FRACTURE 42 0.0022
854 DYSKINESIA 90 0.0022
855 PRODUCT AVAILABILITY ISSUE 50 0.0022
856 HEPATIC FAILURE 66 0.0022
857 ISCHAEMIC STROKE 39 0.0022
858 RASH MACULAR 76 0.0022
859 COLITIS 82 0.0022
860 RASH ERYTHEMATOUS 103 0.0022
861 BLOOD BILIRUBIN INCREASED 58 0.0021
862 INTERSTITIAL LUNG DISEASE 101 0.0021
863 INJECTION SITE REACTION 143 0.0021
864 HYPOCALCAEMIA 39 0.0021
865 PRODUCT USE ISSUE 387 0.0021
866 ANGIOEDEMA 91 0.0021
867 PNEUMONITIS 56 0.0021
868 AGITATION 151 0.0021
869 CHOKING 40 0.0020
870 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
871 PARANOIA 35 0.0020
872 UNDERDOSE 147 0.0020
873 SNEEZING 45 0.0020
874 DERMATITIS 42 0.0020
875 ACCIDENTAL OVERDOSE 73 0.0020
876 CONJUNCTIVITIS 37 0.0020
877 EYE SWELLING 74 0.0020
878 DRUG EFFECT DECREASED 107 0.0020
879 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
880 INFLUENZA LIKE ILLNESS 163 0.0020
881 OSTEONECROSIS 65 0.0020
882 MULTIPLE ORGAN DYSFUNCTION SYNDROME 55 0.0019
883 PHOTOSENSITIVITY REACTION 32 0.0019
884 ILLNESS 199 0.0019
885 HOSPITALISATION 296 0.0019
886 DIABETIC KETOACIDOSIS 46 0.0019
887 EXPOSURE DURING PREGNANCY 119 0.0019
888 SURGERY 112 0.0019
889 JAUNDICE 51 0.0019
890 MUSCULOSKELETAL DISORDER 36 0.0019
891 METASTASES TO BONE 31 0.0019
892 LEUKOPENIA 94 0.0019
893 BONE DENSITY DECREASED 58 0.0018
894 STEVENS-JOHNSON SYNDROME 41 0.0018
895 RESTLESSNESS 67 0.0018
896 EYE IRRITATION 105 0.0018
897 MUSCLE TWITCHING 42 0.0018
898 METASTASES TO LIVER 32 0.0018
899 ERYTHEMA 374 0.0018
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 66 0.0018
901 THERAPEUTIC RESPONSE UNEXPECTED 81 0.0018
902 DEVICE DISLOCATION 78 0.0018
903 PRODUCT QUALITY ISSUE 243 0.0018
904 LACTIC ACIDOSIS 57 0.0018
905 DRUG ADMINISTRATION ERROR 54 0.0018
906 PANCYTOPENIA 98 0.0018
907 LUNG NEOPLASM MALIGNANT 71 0.0017
908 ANAPHYLACTIC REACTION 95 0.0017
909 EPILEPSY 52 0.0017
910 NERVOUS SYSTEM DISORDER 53 0.0017
911 RASH PAPULAR 38 0.0017
912 PRODUCT ADMINISTRATION ERROR 34 0.0017
913 DISEASE RECURRENCE 80 0.0017
914 GLYCOSYLATED HAEMOGLOBIN INCREASED 42 0.0017
915 ABDOMINAL PAIN LOWER 42 0.0017
916 WHITE BLOOD CELL COUNT DECREASED 180 0.0017
917 OFF LABEL USE 1451 0.0017
918 PRODUCT DOSE OMISSION 107 0.0016
919 CRYING 59 0.0016
920 BREAST CANCER FEMALE 43 0.0016
921 DRUG ABUSE 134 0.0016
922 MENTAL DISORDER 70 0.0016
923 DRUG INEFFECTIVE 2115 0.0016
924 ABNORMAL BEHAVIOUR 63 0.0016
925 HEPATOTOXICITY 35 0.0016
926 OCULAR HYPERAEMIA 74 0.0016
927 HEPATIC FUNCTION ABNORMAL 57 0.0015
928 OVERDOSE 329 0.0015
929 ANAPHYLACTIC SHOCK 39 0.0015
930 INTENTIONAL OVERDOSE 97 0.0015
931 INTENTIONAL DOSE OMISSION 43 0.0015
932 INTENTIONAL PRODUCT MISUSE 131 0.0015
933 EYE PRURITUS 50 0.0015
934 DRY SKIN 196 0.0015
935 DISTURBANCE IN ATTENTION 79 0.0015
936 DEATH 1256 0.0015
937 INCORRECT DRUG ADMINISTRATION DURATION 41 0.0015
938 TARDIVE DYSKINESIA 41 0.0015
939 IRRITABILITY 86 0.0014
940 DEVICE MALFUNCTION 99 0.0014
941 INJECTION SITE BRUISING 112 0.0014
942 DRUG DOSE OMISSION 230 0.0014
943 PRODUCT DOSE OMISSION ISSUE 402 0.0014
944 MENTAL IMPAIRMENT 33 0.0014
945 INJECTION SITE HAEMORRHAGE 108 0.0014
946 INCORRECT DOSE ADMINISTERED 307 0.0013
947 PRODUCT PRESCRIBING ERROR 32 0.0013
948 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
949 AGGRESSION 67 0.0013
950 VAGINAL HAEMORRHAGE 58 0.0013
951 NEOPLASM MALIGNANT 89 0.0013
952 DRUG EFFECT INCOMPLETE 47 0.0013
953 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 91 0.0013
954 COVID-19 223 0.0013
955 ECZEMA 66 0.0013
956 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 69 0.0013
957 SEIZURE 143 0.0012
958 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 221 0.0012
959 PAIN OF SKIN 33 0.0012
960 PLASMA CELL MYELOMA 46 0.0012
961 NEOPLASM PROGRESSION 41 0.0012
962 NEUTROPHIL COUNT DECREASED 48 0.0012
963 THERAPY CESSATION 60 0.0012
964 SUICIDAL IDEATION 107 0.0012
965 ANGER 39 0.0012
966 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
967 NEUTROPENIA 152 0.0011
968 PSYCHOTIC DISORDER 33 0.0011
969 DISEASE PROGRESSION 132 0.0011
970 INJECTION SITE MASS 41 0.0011
971 MOOD SWINGS 34 0.0011
972 INJECTION SITE PAIN 321 0.0010
973 MULTIPLE SCLEROSIS 49 0.0010
974 SKIN BURNING SENSATION 73 0.0010
975 THERAPY INTERRUPTED 72 0.0010
976 FEBRILE NEUTROPENIA 62 0.0009
977 INJECTION SITE PRURITUS 62 0.0009
978 SUICIDE ATTEMPT 56 0.0009
979 INJECTION SITE SWELLING 69 0.0009
980 BREAST CANCER 81 0.0009
981 MULTIPLE SCLEROSIS RELAPSE 58 0.0008
982 MALIGNANT NEOPLASM PROGRESSION 86 0.0008
983 PROSTATE CANCER 67 0.0008
984 EXTRA DOSE ADMINISTERED 33 0.0008
985 WITHDRAWAL SYNDROME 34 0.0008
986 SKIN IRRITATION 34 0.0007
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 34 0.0007
988 INJECTION SITE ERYTHEMA 90 0.0007
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 147 0.0007
990 DRUG WITHDRAWAL SYNDROME 63 0.0007
991 DRUG DEPENDENCE 90 0.0006
992 DEVICE ISSUE 49 0.0005
993 ACNE 35 0.0005
994 ACCIDENTAL EXPOSURE TO PRODUCT 47 0.0005
995 NO ADVERSE EVENT 77 0.0004